Navigation Links
NIH supports new research strategy for finding a cure for HIV
Date:7/11/2011

An international team led by researchers from the University of California, San Francisco and the nonprofit Vaccine and Gene Therapy Institute of Port St. Lucie, Fla., has received a major grant from the National Institutes of Health to develop a strategy to eradicate HIV from the body.

The team includes academic, industry and governmental scientists.

"Even though existing anti-HIV drugs have dramatically changed the course of HIV disease for many patients, particularly in Western/developed countries, the drugs are expensive and require daily dosing for life, they are not available to everyone who needs them, they have side effects and they do not fully restore health," said Steven Deeks, MD, a professor of medicine at the UCSF Division of HIV/AIDS at San Francisco General Hospital and one of the three principal investigators.

Moreover, he said, "HIV continues to kill millions of people in developing countries, including regions of Africa, Asia and Eastern Europe. Our hope is to have a single, or more likely, a combination regimen that truly cures the disease and that we could eventually deliver to people infected with HIV throughout the world."

The award will total over $4 million a year for five years, and consists of seven projects and three core programs. The research project has three broadly defined objectives. One is to define HIV's reservoirthe regions within organs such as the gut, lymph tissue and the brain where HIV remains dormant at low levels even when current combination antiretroviral therapy prevents further replication of the virus in the body. The second is to understand how this reservoir is created and maintained. The third is to test potential treatments.

"In order to develop a cure that would eradicate HIV/AIDS, we need to be able to first determine and understand all of the places and types of cells in the body where the HIV virus can hide or lie dormant, allowing it to persist in patients even after years of successful suppressive therapy. Then we can test treatments that target and eliminate these viral reservoirs without activating the rest of the immune system," said study co-principal investigator Rafick-Pierre Sekaly, PhD, co-director and chief scientific officer of the Vaccine and Gene Therapy Institute in Florida.

The National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, is the primary funding organization and announced this award as one of its Martin Delaney Collaboratory grants that seek to advance progress towards a cure through public-private partnerships between government, industry and academia. NIAID is announcing three Collaboratory grants totaling over $14 million per year for up to five years. Co-funding is also provided by the National Institute of Mental Health.

"Marty Delaney, who died of liver cancer in 2009, was a friend of mine and a hero," said co-principal investigator, Joseph ("Mike") McCune, MD, PhD, chief of the UCSF Division of Experimental Medicine. "Starting in the darkest days of the epidemic, when he founded Project Inform, and throughout the next 25 years, he was one of the most influential and thoughtful leaders in the struggle against HIV, helping researchers to work together and spearheading efforts to get better therapies to patients. Unlocking the secret of how to cure HIV would be a fitting tribute to his legacy."

The research team includes collaborators from Johns Hopkins University, the Vaccine and Gene Therapy Institute at Oregon Health and Science University (OHSU), the Oregon National Primate Research Center at OHSU, the University of Minnesota, Monash University, the American Foundation for AIDS Research (amfAR), the Blood Systems Research Institute, the Karolinska Institute, the University of Miami, and the University of California, Davis. Merck Research Labs is the team's industry partner, although Merck will not be receiving any funding for its participation in the project.


'/>"/>

Contact: Jeff Sheehy
jsheehy@ari.ucsf.edu
415-597-8165
University of California - San Francisco
Source:Eurekalert

Related medicine news :

1. NASBE Supports First Lady Michelle Obama in Fight Against Childhood Obesity
2. Study supports alternative anti-seizure medication following acute brain injury
3. Minnesota Chiropractic Association Supports Lawsuit Against BCBSA
4. JPMA Supports CPSC Chairman Tenenbaum's Continued Safety Efforts
5. AT&T Foundations $50,000 Donation to National Health Foundation Supports Teen Pregnancy Prevention Program
6. reco jeans Supports Children With Rare Diseases
7. ChildCare Education Institute Supports the First Ladys Efforts to Reduce Childhood Obesity
8. WellNet Supports HPM Institute Director in Calling for More Active Enterprise Involvement in Managing Healthcare Quality and Costs
9. James Scott Farrin Supports Radiothon for Duke Children's Hospital
10. MARC Coalition Supports Medicare Secondary Payer Enhancement Act (MSPEA)/H.R. 4796
11. Hot Tub Company Helps Swimmers Thaw and Supports Special Olympics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... Coral Springs, FL (PRWEB) , ... July 28, 2017 , ... Kevin Harrington, one of ... are pleased to announce the launch of a new DRTV campaign with My Real Earth. ... we put on our bodies is just as important as what we put in our ...
(Date:7/28/2017)... ... 2017 , ... The DuPage County law firm of Mirabella Kincaid Frederick ... Ms. Cusack joins the team ready to provide clients with vigorous representation in ... in Peoria, Illinois, with a BA in Social Work. She earned her JD from ...
(Date:7/28/2017)... ... ... Becker's Healthcare as they host their 3rd Annual Health IT + Revenue Cycle Conference ... Security, Telehealth, Mobile Health, Revenue Cycle Optimization, Predictive Analytics, Cerner, Denials, Patient clearance and ... W. Bush, 43rd President of the United States of America , Sugar ...
(Date:7/28/2017)... , ... July 28, 2017 , ... ... assistance and financial consultations to business owners and families across east Texas, is ... to benefit veterans in the greater Dallas area. , America’s Mighty Warriors offers ...
(Date:7/28/2017)... ... July 28, 2017 , ... Leyden Insurance Agency, a Chicago based firm ... and around Cook County, is working in conjunction with the Conner T. Lowry Memorial ... Established in honor of a brave soldier who is still dearly missed by his ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/14/2017)... 14, 2017 Endo International plc (NASDAQ: ENDP ... 8, 2017.  Members of its senior management team will host a ... 8:30 a.m. ET. The dial-in number to access ... (678) 509-7598, and the passcode is 45397076. Please dial in 10 ... A replay of the call will be available ...
(Date:7/13/2017)... , July 13, 2017  New York City-based market ... pharmaceutical markets should be aware of.  From new products to ... are detailed in a recently completed study, Potential Pipeline ... 1.  Age-Driven Growth - ... have been aware of the impact the growing population and, ...
Breaking Medicine Technology: